Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Epidemiology of Single Versus Multiple Substance Use Disorders
Ish P. Bhalla, Elina A. Stefanovics, Robert A. Rosenheck
Medical Care (2017) Vol. 55, Iss. Suppl 2, pp. S24-S32
Closed Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration
Lewei Lin, Amy S. B. Bohnert, Frederic C. Blow, et al.
Addiction (2020) Vol. 116, Iss. 1, pp. 96-104
Open Access | Times Cited: 89
The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates
Alexander S. Hatoum, Emma C. Johnson, Sarah M. C. Colbert, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 10, pp. 1739-1745
Open Access | Times Cited: 83
Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules
Pablo Berríos‐Cárcamo, Mauricio Quezada, Marı́a Elena Quintanilla, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 830-830
Open Access | Times Cited: 71
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns
Alexandra M. Mellis, Marc N. Potenza, Jessica Hulsey
Journal of Substance Abuse Treatment (2020) Vol. 121, pp. 108180-108180
Open Access | Times Cited: 54
Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years
Christine Timko, Xiaotong Han, Erin L. Woodhead, et al.
Journal of Studies on Alcohol and Drugs (2018) Vol. 79, Iss. 5, pp. 799-807
Open Access | Times Cited: 56
Comparison of opioid use disorder among male veterans and non‐veterans: Disorder rates, socio‐demographics, co‐morbidities, and quality of life
Taeho Greg Rhee, Robert A. Rosenheck
American Journal on Addictions (2019) Vol. 28, Iss. 2, pp. 92-100
Open Access | Times Cited: 52
Unique versus shared associations between self-reported behavioral addictions and substance use disorders and mental health problems: A commonality analysis in a large sample of young Swiss men
Simon Marmet, Joseph Studer, Matthias Wicki, et al.
Journal of Behavioral Addictions (2019) Vol. 8, Iss. 4, pp. 664-677
Open Access | Times Cited: 43
Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders: a prospective longitudinal cohort study
Jens Hetland, Astri J. Lundervold, Aleksander H. Erga
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Readiness-to-Change and Treatment Outcomes among Individuals with Substance Use Disorders at Post-Incarceration
Kelsey Watterson, Jordan Nelon, Linda Grove-Paul, et al.
Research Square (Research Square) (2025)
Closed Access
Stroke Risk in Unstably Housed Women: The Role of Cocaine and Alcohol Co-Use
Akanksha Vaidya, Torsten B. Neilands, Felicia C. Chow, et al.
Stroke (2025)
Closed Access
Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast
Pablo K. Valente, Angela R. Bazzi, Ellen Childs, et al.
International Journal of Drug Policy (2020) Vol. 85, pp. 102934-102934
Open Access | Times Cited: 38
Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders
Taeho Greg Rhee, Robert A. Rosenheck
Journal of Affective Disorders (2019) Vol. 252, pp. 450-457
Open Access | Times Cited: 36
Initiating Opioid Agonist Treatment for Opioid use Disorder Nationally in the Veterans Health Administration: Who Gets What?
Ajay Manhapra, Elina A. Stefanovics, Robert A. Rosenheck
Substance Abuse (2019) Vol. 41, Iss. 1, pp. 110-120
Closed Access | Times Cited: 35
Are you thinking what I’m thinking? Defining what we mean by “polysubstance use.”
Amanda M. Bunting, Riley D. Shearer, Ashley N. Linden‐Carmichael, et al.
The American Journal of Drug and Alcohol Abuse (2023) Vol. 50, Iss. 1, pp. 1-7
Closed Access | Times Cited: 12
A multicenter cross-sectional study of gambling disorder among patients with methamphetamine use disorder in drug rehabilitation centers: prevalence, correlates, and network analysis
Pu Peng, Yuzhu Hao, Xiaojie Zhang, et al.
Annals of General Psychiatry (2025) Vol. 24, Iss. 1
Open Access
Polysubstance Use among Patients of Opioid Use Disorder on Buprenorphine Opioid Substitution Therapy Based on Urine Drug Test Analysis
Shubham Govani, Pooja Shatadal, Ritambhara Mehta
Annals of Indian Psychiatry (2025)
Closed Access
A Change in Perspective: From Dual Diagnosis to Multimorbidity
Ish P. Bhalla, Robert A. Rosenheck
Psychiatric Services (2017) Vol. 69, Iss. 1, pp. 112-116
Open Access | Times Cited: 38
Antipsychotic Prescriptions Among Adults With Major Depressive Disorder in Office-Based Outpatient Settings
Taeho Greg Rhee, Somaia Mohamed, Robert A. Rosenheck
The Journal of Clinical Psychiatry (2018) Vol. 79, Iss. 2, pp. 17m11970-17m11970
Open Access | Times Cited: 34
Effect of Assertive Community Treatment for Patients with Substance Use Disorder: A Systematic Review
Louise Penzenstadler, Carina Soares, Eleonora Anci, et al.
European Addiction Research (2019) Vol. 25, Iss. 2, pp. 56-67
Open Access | Times Cited: 34
Mental health multimorbidity and poor quality of life in patients with schizophrenia
Ish P. Bhalla, Elina A. Stefanovics, Robert A. Rosenheck
Schizophrenia Research (2018) Vol. 201, pp. 39-45
Closed Access | Times Cited: 33
Cannabis use among military veterans: A great deal to gain or lose?
Jasmine Turna, James MacKillop
Clinical Psychology Review (2021) Vol. 84, pp. 101958-101958
Open Access | Times Cited: 24
Frequencies of emergency department use and hospitalization comparing patients with different types of substance or polysubstance-related disorders
Bahram Armoon, Guy Grenier, Zhirong Cao, et al.
Substance Abuse Treatment Prevention and Policy (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 23
Buprenorphine prescribing for opioid use disorder in medical practices: can office‐based out‐patient care address the opiate crisis in the United States?
Taeho Greg Rhee, Robert A. Rosenheck
Addiction (2019) Vol. 114, Iss. 11, pp. 1992-1999
Open Access | Times Cited: 27
Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch
Kenneth Blum, Jean Lud Cadet, Mark S. Gold
Journal of the Neurological Sciences (2020) Vol. 420, pp. 117252-117252
Open Access | Times Cited: 26
Multiple Substance Use Disorders and Self-Reported Cognitive Function in U.S. Adults: Associations and Sex-Differences in a Nationally Representative Sample
Zoe Bourgault, Dafna Sara Rubin-Kahana, Ahmed N. Hassan, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top